10/01/2026
Many have asked why we’re launching this search initiative. My answer is simple: because it’s our moral duty.
FOP (fibrodysplasia ossificans progressiva) is ultra-rare — only ~900 patients have been identified worldwide, though over 8,000 are estimated to be living with it. Yet 90% are misdiagnosed.
The hallmark sign? In 98% of cases, the big toe is malformed and missing the middle joint — a clue visible at birth. But most healthcare professionals have never been trained to spot it.
Too often, FOP is mistaken for cancer. Biopsies are performed — and that trauma accelerates the disease. Bone begins to form in muscles, tendons, and ligaments, severely restricting movement. A skeleton, growing over a skeleton.
If we find these patients early, we can prevent harm, end unnecessary suffering, and change lives.
I’m proud that LeadPath is the first organization in the region to bring FOP forward.
We will continue navigating the path less taken — for every FOP patient and every family.